Immunology Biomarker Lead: Strategy Director (Hybrid)

Stiftung Weizenkorn in Basel is seeking a Therapeutic Area Biomarker Lead (TABL) to drive biomarker strategies for clinical trials in immunology. You will work with a dedicated team to support the development of robust biomarker plans and ensure successful integration into clinical protocols.The ideal candidate will have a PhD in Life Sciences and a minimum of 5 years of experience in the pharmaceutical or biotech industry, with a focus on clinical decision-making. Strong communication and leadership skills are essential. #J-18808-Ljbffr